Fulcrum Therapeutics
FULC
FULC
119 hedge funds and large institutions have $243M invested in Fulcrum Therapeutics in 2024 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 33 increasing their positions, 40 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
18% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 40
27% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 33
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
119
Holding in Top 10
–
Calls
$5.45M
Puts
$218K
Top Buyers
| 1 | +$10.1M | |
| 2 | +$5.55M | |
| 3 | +$4.7M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$3.48M |
| 5 |
EAM
Exome Asset Management
New York
|
+$1.33M |
Top Sellers
| 1 | -$8.37M | |
| 2 | -$7.68M | |
| 3 | -$4.77M | |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
-$3.82M |
| 5 |
BlackRock
New York
|
-$2.52M |